naturalX Health Ventures
Overview
naturalX Health Ventures is a €100 million venture capital fund backed by the Schwabe Group that focuses on investing in Consumer Health startups, primarily at the Series-A stage, across Europe.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Aktiia | May 2025 | Series B | Co-investor |
| Hilo | May 2025 | Series B | Co-investor |
| Jutro Medical | Dec 2025 | Series A | Co-investor |
| mybacs | Oct 2023 | Series A | Lead |
| Ilant Health | Jun 2026 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is naturalX Health Ventures based?
naturalX Health Ventures is headquartered in Karlsruhe, Germany.
When was naturalX Health Ventures founded?
naturalX Health Ventures was founded in 2022.
How many portfolio companies does naturalX Health Ventures have?
naturalX Health Ventures has 6 portfolio companies in Caplight's dataset.
What are some companies in naturalX Health Ventures's portfolio?
Portfolio companies visible on Caplight include Aktiia, Hilo, Jutro Medical, mybacs, Ilant Health.
What was naturalX Health Ventures's most recent investment shown here?
naturalX Health Ventures's most recent investment in this portfolio sample was in Ilant Health in 2026.
What sectors does naturalX Health Ventures focus on?
naturalX Health Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Consumer & Commerce, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Consumer & Commerce.
What company stages does naturalX Health Ventures focus on?
naturalX Health Ventures typically invests at the Early stage.
What is naturalX Health Ventures's AUM?
naturalX Health Ventures's assets under management are estimated between $108.0M and $108.0M.